Home

sfaturi principal material adaptive biotechnologies stock lansa A tăia Administra

Biotech Companies Soar in Stock Market Debuts - WSJ
Biotech Companies Soar in Stock Market Debuts - WSJ

Seattle's Adaptive Biotechnologies upsizes stock offering on strong  investor interest | The Seattle Times
Seattle's Adaptive Biotechnologies upsizes stock offering on strong investor interest | The Seattle Times

Do Hedge Funds Love Adaptive Biotechnologies Corporation (ADPT)?
Do Hedge Funds Love Adaptive Biotechnologies Corporation (ADPT)?

Stocks to Buy: ADPT Adaptive Biotechnologies Corporation 2021 03 08 -  YouTube
Stocks to Buy: ADPT Adaptive Biotechnologies Corporation 2021 03 08 - YouTube

Buy or sell Adaptive Biotechnologies stock pre IPO via an EquityZen fund |  EquityZen
Buy or sell Adaptive Biotechnologies stock pre IPO via an EquityZen fund | EquityZen

Do Options Traders Know Something About Adaptive Biotechnologies (ADPT)  Stock We Don't?
Do Options Traders Know Something About Adaptive Biotechnologies (ADPT) Stock We Don't?

143 Reviews: What Is It Like to Work At Adaptive Biotechnologies? |  Glassdoor
143 Reviews: What Is It Like to Work At Adaptive Biotechnologies? | Glassdoor

Adaptive Biotechnologies stock soars 90% after ringing Nasdaq opening bell  following $300M IPO – GeekWire
Adaptive Biotechnologies stock soars 90% after ringing Nasdaq opening bell following $300M IPO – GeekWire

How to buy Adaptive Biotechnologies (ADPT:NASDAQ) shares in Australia |  Finder
How to buy Adaptive Biotechnologies (ADPT:NASDAQ) shares in Australia | Finder

Adaptive Biotechnologies Corporation (ADPT) Stock Price, News & Info | The  Motley Fool
Adaptive Biotechnologies Corporation (ADPT) Stock Price, News & Info | The Motley Fool

Big debut: Shares of Adaptive Biotechnologies rise 100% on first day as  public company – GeekWire
Big debut: Shares of Adaptive Biotechnologies rise 100% on first day as public company – GeekWire

Adaptive Biotechnologies: Stock Isn't Cheap (NASDAQ:ADPT) | Seeking Alpha
Adaptive Biotechnologies: Stock Isn't Cheap (NASDAQ:ADPT) | Seeking Alpha

Adaptive Biotechnologies Stock Chart - ADPT
Adaptive Biotechnologies Stock Chart - ADPT

Insiders of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) must have  made a tidy sum after selling stock currently worth US$35.34 at US$39.64 |  Nasdaq
Insiders of Adaptive Biotechnologies Corporation (NASDAQ:ADPT) must have made a tidy sum after selling stock currently worth US$35.34 at US$39.64 | Nasdaq

Is Adaptive Biotechnologies Corporation (ADPT) Stock Rising Now?
Is Adaptive Biotechnologies Corporation (ADPT) Stock Rising Now?

Is Adaptive Biotechnologies Corporation (ADPT) Stock Rising Now?
Is Adaptive Biotechnologies Corporation (ADPT) Stock Rising Now?

ADAPTIVE BIOTECHNOLOGIES CORPORATION : ADPT Stock Price | US00650F1093 |  MarketScreener
ADAPTIVE BIOTECHNOLOGIES CORPORATION : ADPT Stock Price | US00650F1093 | MarketScreener

NASDAQ, ADPT End of Day and Historical Stock Data [Adaptive Biotechnologies  Corp]
NASDAQ, ADPT End of Day and Historical Stock Data [Adaptive Biotechnologies Corp]

Articles with Adaptive Biotechnologies
Articles with Adaptive Biotechnologies

ADPT | Adaptive Biotechnologies Stock Price
ADPT | Adaptive Biotechnologies Stock Price

Adaptive Biotechnologies Corporation (ADPT) Stock Price Today, Quote & News  | Seeking Alpha
Adaptive Biotechnologies Corporation (ADPT) Stock Price Today, Quote & News | Seeking Alpha

Is Adaptive Biotechnologies Corporation (ADPT) Stock Rising Now?
Is Adaptive Biotechnologies Corporation (ADPT) Stock Rising Now?

ADPT Stock Forecast, Price & News (Adaptive Biotechnologies)
ADPT Stock Forecast, Price & News (Adaptive Biotechnologies)

Adaptive Biotechnologies Stock Quote. ADPT - Stock Price, News, Charts,  Message Board, Trades
Adaptive Biotechnologies Stock Quote. ADPT - Stock Price, News, Charts, Message Board, Trades

Adaptive Biotechnologies (NASDAQ:ADPT shareholders incur further losses as  stock declines 4.1% this week, taking one-year losses to 54% | Nasdaq
Adaptive Biotechnologies (NASDAQ:ADPT shareholders incur further losses as stock declines 4.1% this week, taking one-year losses to 54% | Nasdaq